Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05116514

Evaluation of the Impact of Case Manager Intervention on the 3-year Psychotic Episode Recurrence Rate in Patients Aged 16 to 30 Years With a First Psychotic Episode.

Evaluation of the Impact of Case Manager Intervention on the 3-year Psychotic Episode Recurrence Rate in Patients Aged 16 to 30 Years With a First Psychotic Episode. Randomized, Open-label, Multicenter Controlled Study With Blinded Evaluation.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
256 (estimated)
Sponsor
Centre Hospitalier Universitaire de Nīmes · Academic / Other
Sex
All
Age
16 Years – 30 Years
Healthy volunteers
Not accepted

Summary

The study investigators hypothesize that the intervention of case managers specifically trained in case management of early psychosis will change the paradigm of care of a first psychotic episode from the current organization of the care system. Indeed, the creation of specific services for emerging psychotic disorders cannot easily be generalized throughout the country and requires specific funding. The intervention of case managers according to the recommendations of good practices will make it possible to propose the fundamental principles of early intervention to young patients and their families on a large scale throughout the territory, namely: personalized and proactive accompaniment, psycho-education of the pathology and treatments, involvement and support of the families, and support for socio-professional reintegration

Conditions

Interventions

TypeNameDescription
OTHERCase managementRegular and personalized follow-up by a case manager using a "case management" approach, updated every 3 months

Timeline

Start date
2021-09-27
Primary completion
2028-09-01
Completion
2028-11-01
First posted
2021-11-11
Last updated
2025-12-31

Locations

6 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05116514. Inclusion in this directory is not an endorsement.

Evaluation of the Impact of Case Manager Intervention on the 3-year Psychotic Episode Recurrence Rate in Patients Aged 1 (NCT05116514) · Clinical Trials Directory